- Home
- ILAG vs DCOY Comparison
ILAG vs DCOY Comparison
Compare ILAG & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ILAG | DCOY |
|---|---|---|
| Founded | 1981 | N/A |
| Country | Hong Kong | United States |
| Employees | 238 | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ILAG | DCOY |
|---|---|---|
| Price | $2.48 | $0.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 4.6K | ★ 145.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.57 |
| 52 Week High | $7.19 | $1.41 |
Technical Indicators
Market Signals| Indicator | ILAG | DCOY |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 39.60 |
| Support Level | $0.42 | N/A |
| Resistance Level | $3.31 | $0.83 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 23.70 | 23.64 |
Price Performance
Historical ComparisonAbout ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About DCOY Decoy Therapeutics Inc. Common Stock
Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.